Ruth G.M. Keijsers

Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis

Adriane D.M. Vorselaars, Heleen A. Crommelin, Vera H.M. Deneer et al. · European Respiratory Journal · 2015 · 150 citations · Full text

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis

Adriane D.M. Vorselaars, Anouk Verwoerd, Coline H.M. van Moorsel et al. · European Respiratory Journal · 2013 · 142 citations · Full text

Disease Progression, Immunodeficiencies, Prognosis +21

18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.

Ruth G.M. Keijsers, J. Fred Verzijlbergen, D.M. van Diepen et al. · PubMed · 2008 · 92 citations

18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis

Ruth G.M. Keijsers, Fred Verzijlbergen, Wim J.G. Oyen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 90 citations

Autoimmune Disease, Immunology, Pathology +2

18F-FDG PET as a predictor of pulmonary function in sarcoidosis.

Ruth G.M. Keijsers, E J Verzijlbergen, Jules M. van den Bosch et al. · PubMed · 2011 · 89 citations